Annual Drug Patent Expirations for BRYHALI
Bryhali is a drug marketed by Bausch and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
Drug patent litigation for BRYHALI.
This drug has twenty-two patent family members in nineteen countries.
The generic ingredient in BRYHALI is halobetasol propionate. One supplier is listed for this compound. Additional details are available on the halobetasol propionate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
